Effect of PCSK9 Inhibitors on Calcific Aortic Valve Disease a Prospective Randomized Controlled Trial
Latest Information Update: 14 May 2024
At a glance
- Drugs Alirocumab (Primary) ; Evolocumab (Primary) ; HMG-CoA reductase inhibitors (Primary)
- Indications Aortic valve stenosis
- Focus Therapeutic Use
- Acronyms EPISODE
- 28 Jan 2024 Planned initiation date changed from 1 Jul 2021 to 1 Feb 2024.
- 13 Dec 2023 Planned End Date changed from 1 Jan 2024 to 1 Jan 2028.
- 13 Dec 2023 Planned primary completion date changed from 1 Dec 2023 to 1 Dec 2027.